413 related articles for article (PubMed ID: 27396304)
1. MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?
Nadim WD; Simion V; Benedetti H; Pichon C; Baril P; Morisset-Lopez S
Curr Neuropharmacol; 2017; 15(2):260-275. PubMed ID: 27396304
[TBL] [Abstract][Full Text] [Related]
2. Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.
Simion V; Nadim WD; Benedetti H; Pichon C; Morisset-Lopez S; Baril P
Curr Neuropharmacol; 2017; 15(2):276-290. PubMed ID: 27397479
[TBL] [Abstract][Full Text] [Related]
3. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
[TBL] [Abstract][Full Text] [Related]
4. Micro-RNAs in cognition and cognitive disorders: Potential for novel biomarkers and therapeutics.
Woldemichael BT; Mansuy IM
Biochem Pharmacol; 2016 Mar; 104():1-7. PubMed ID: 26626188
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.
Xu B; Hsu PK; Karayiorgou M; Gogos JA
Neurobiol Dis; 2012 May; 46(2):291-301. PubMed ID: 22406400
[TBL] [Abstract][Full Text] [Related]
6. microRNAs and Neurodegenerative Diseases.
Qiu L; Tan EK; Zeng L
Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
[TBL] [Abstract][Full Text] [Related]
7. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.
Gupta S; Verma S; Mantri S; Berman NE; Sandhir R
Drug Dev Res; 2015 Nov; 76(7):397-418. PubMed ID: 26359796
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.
Petrek H; Yu AM
Pharmacol Res Perspect; 2019 Dec; 7(6):e00528. PubMed ID: 31859460
[TBL] [Abstract][Full Text] [Related]
9. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
[TBL] [Abstract][Full Text] [Related]
10. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
Roy B; Lee E; Li T; Rampersaud M
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
[TBL] [Abstract][Full Text] [Related]
11. Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.
Du L; Pertsemlidis A
J Mol Cell Biol; 2011 Jun; 3(3):176-80. PubMed ID: 21278200
[TBL] [Abstract][Full Text] [Related]
12. Antagonizing Increased
Vangoor VR; Reschke CR; Senthilkumar K; van de Haar LL; de Wit M; Giuliani G; Broekhoven MH; Morris G; Engel T; Brennan GP; Conroy RM; van Rijen PC; Gosselaar PH; Schorge S; Schaapveld RQJ; Henshall DC; De Graan PNE; Pasterkamp RJ
J Neurosci; 2019 Jun; 39(26):5064-5079. PubMed ID: 31015341
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and synaptic plasticity--a mutual relationship.
Aksoy-Aksel A; Zampa F; Schratt G
Philos Trans R Soc Lond B Biol Sci; 2014 Sep; 369(1652):. PubMed ID: 25135976
[TBL] [Abstract][Full Text] [Related]
14. ISCHEMIRs: Finding a Way Through the Obstructed Cerebral Arteries.
Nampoothiri SS; Menon HV; Das D; Krishnamurthy RG
Curr Drug Targets; 2016; 17(7):800-10. PubMed ID: 25981603
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.
Trino S; Lamorte D; Caivano A; Laurenzana I; Tagliaferri D; Falco G; Del Vecchio L; Musto P; De Luca L
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401684
[TBL] [Abstract][Full Text] [Related]
16. Neuroepigenetics of memory formation and impairment: the role of microRNAs.
Saab BJ; Mansuy IM
Neuropharmacology; 2014 May; 80():61-9. PubMed ID: 24486712
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains.
Satoh J
J Pharmacol Sci; 2010; 114(3):269-75. PubMed ID: 20953120
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29: a potential therapeutic target for systemic sclerosis.
Peng WJ; Tao JH; Mei B; Chen B; Li BZ; Yang GJ; Zhang Q; Yao H; Wang BX; He Q; Wang J
Expert Opin Ther Targets; 2012 Sep; 16(9):875-9. PubMed ID: 22793265
[TBL] [Abstract][Full Text] [Related]
19. Neurodegenerative Disorders Treatment: The MicroRNA Role.
Ridolfi B; Abdel-Haq H
Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA networks direct neuronal development and plasticity.
Olde Loohuis NF; Kos A; Martens GJ; Van Bokhoven H; Nadif Kasri N; Aschrafi A
Cell Mol Life Sci; 2012 Jan; 69(1):89-102. PubMed ID: 21833581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
